Genital infections occurred less frequently, and serious complications such as diabetic ketoacidosis, Fournier's gangrene, or amputations were notably absent, suggesting a generally favorable infection‐related safety profile for SGLT2 inhibitors in this population. This evidence concerns the gene SLC5A2 and infection.